Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Bruker Daltonics Launches Worldwide CLINPROT FORUM

Published: Monday, April 03, 2006
Last Updated: Tuesday, April 04, 2006
Bookmark and Share
The CLINPROT FORUM will support of customers in protein/peptide biomarker discovery and validation, as well as in clinical and applied proteomics.

Bruker Daltonics has announced the launch of its CLINPROT FORUM for the support of customers in protein/peptide biomarker discovery and validation, as well as in clinical and applied proteomics.

The CLINPROT™ product line (for research use only) covers various aspects of biomarker analysis with special emphasis on body-fluid and tissue profiling, MALDI molecular imaging, and protein/peptide-based micro-organism identification and classification. The CLINPROT solution includes magnetic bead sample pre-fractionation, MALDI-TOF analysis and streamlined bioinformatics and visualization tools.

The goal of the newly created international CLINPROT FORUM is to establish efficient networking amongst a rapidly growing worldwide community of CLINPROT users. This discussion forum covers various aspects of clinical proteomics, such as biofluid profiling and validation, biomarker identification, the MALDI Molecular Imager™ and the MALDI BioTyper™ for microorganism identification.

The CLINPROT FORUM facilitates efficient information exchange and should stimulate the formation of research collaborations between different laboratories. Special discussion threads include topics like sample preparation, standardization, biomarker identification and bioinformatics methods. A CLINPROT FORUM download site provides the latest protocols for sample preparation with CLINPROT magnetic beads, as well as recent publication lists and application notes.

The CLINPROT FORUM, which is moderated by expert Bruker application scientists, is available for all Bruker Daltonics customers and can be reached under

Dr. Nils von Neuhoff, Head of Molecular Genetic Diagnostics, Institute of Cell and Molecular Pathology at Hannover Medical School, Germany, commented: "Researchers in the field of proteomic biomarker analysis and profiling of body fluids need to cover knowledge in diverse areas, like standardization of sample preparation, mass spectrometry and sophisticated mathematical approaches for pattern matching.

“Last but not least, they need to have a deep clinical knowledge concerning useful definitions of matching sample cohorts, anamnesis of patients and therapy decisions. For all those interdisciplinary tasks, it is very helpful to have the backup of a network of leading scientists from all over the world with special knowledge in different sub-disciplines of clinical proteomics. The collection and distribution of the latest protocols supplied in CLINPROT FORUM is of additional benefit for all participants."

Dr. Wolfgang Pusch, Assistant Vice President for Clinical Research Solutions at Bruker Daltonics, explained: "In our CLINPROT customer group, we have deep and diverse knowledge about biomarker analysis by means of mass spectrometry, but it is distributed all over the world from Asia/Pacific to Europe to the Americas. Some of these experts do not have the chance to meet personally and exchange information face-to-face on a regular basis."

" Our new CLINPROT FORUM will facilitate networking between our customers, and moreover accelerate the dissemination of best practices and protocols, of relevant recent literature and publications, as well as of timely CLINPROT method updates."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Acetaldehyde and Formaldehyde Content in Foods
Korean researchers have determined the content of the toxic and carcinogenic aldehydes, acetaldehyde and formaldehyde, in a variety of food groups.
Combining the Power of Mass Spectrometry & Microscopy
A tool that provides world-class microscopy and spatially resolved chemical analysis shows considerable promise for advancing a number of areas of study, including chemical science, pharmaceutical development and disease progression.
Increasing Vitamin D Supplementation
New study from ETH Zurich finds that elderly women should consume more vitamin D than previously recommended during the winter months.
Advancing Lithium-Ion Battery Research
The increasing number of components in a lithium-ion battery makes it essential to use a variety of analytical methods to attain complete characterization.
Clearest Ever Images of Enzyme that Plays Key Roles in Aging, Cancer
UCLA-led research on telomerase could lead to new strategies for treating disease
Fruit Fly Pheromone Flags Great Real Estate for Starting a Family
Finding could aid efforts to control mosquito-borne diseases like malaria by manipulating odorants
Education and Expense: The Barriers to Mass Spectrometry in Clinical Laboratories?
Here we examine the perceived barriers to mass spec in clinical laboratories and explore the possible drivers behind the recent shift in uptake of the technology in clinical settings.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos